Rubeola is the medical term for measles, a highly contagious viral infection that causes fever, cough, and a distinctive full-body rash. It is not the same as rubella (German measles), despite the similar-sounding names. Measles remains one of the most contagious diseases known to medicine: a single infected person can spread the virus to up to 18 others.
Rubeola vs. Rubella
The names sound almost identical, which causes real confusion. They are two completely different diseases caused by two different viruses. Rubeola (measles) is the more severe of the two. It produces a high fever, a bold red rash that tends to merge into large patches, and carries a significant risk of serious complications like pneumonia and brain inflammation. Rubella, by contrast, is a milder illness with a low-grade fever and a fainter rash that stays as distinct spots and doesn’t merge together.
Rubella is also recognizable by swollen lymph nodes behind the ears and at the back of the neck, which can persist for weeks. Its rash lasts about three days. Measles produces a rash that typically lasts five to six days and is preceded by several days of feeling genuinely sick. Both are prevented by the MMR vaccine.
What Causes Measles
The measles virus is an RNA virus in the Paramyxoviridae family. There is only one serotype, which means the virus doesn’t shift into meaningfully different strains the way influenza does. This is why a single vaccine has remained effective for decades.
The virus first infects immune cells that patrol the airway lining. These infected immune cells then carry the virus deeper into the body, where it spreads to the airway tissue itself using a specific docking point on epithelial cells called nectin-4. This two-step process, immune cells first, then airway tissue, explains why measles causes such widespread illness rather than staying confined to the nose and throat.
How Measles Spreads
Measles spreads through the air. When an infected person coughs or sneezes, viral particles can linger in the air or on surfaces for up to two hours. You don’t need to be in the same room at the same time as an infected person to catch it. Walking into a room they left an hour ago can be enough.
A person with measles is contagious starting about four days before the rash appears and continuing for about four days after. This is part of what makes measles so difficult to contain: people are spreading it before they even know they’re sick.
Symptoms and Timeline
After exposure, there’s a silent incubation period of about 11 to 12 days before anything happens. Then the illness unfolds in stages.
The first symptoms are what doctors call the prodrome: high fever, a persistent cough, runny nose, and red, watery eyes. This phase looks a lot like a bad cold or flu, lasting two to four days. Two to three days into these early symptoms, tiny white spots may appear on the inside of the cheeks. These are called Koplik spots, and they’re unique to measles. If you see them, the diagnosis is essentially confirmed before the rash even shows up.
The rash itself appears three to five days after the first symptoms. It typically starts on the face and hairline, then spreads downward across the trunk, arms, and legs over the next few days. The spots are flat to slightly raised, red, and tend to merge together into larger blotchy areas. The rash lasts five to six days. Fever often spikes to its highest point in the first day or two of the rash, sometimes reaching 104°F (40°C) or higher.
Potential Complications
Measles is not just a rash. It temporarily suppresses the immune system, which opens the door to secondary infections. Pneumonia is the most common serious complication and the leading cause of measles-related death in children. Ear infections are also frequent and can lead to permanent hearing loss.
The most feared complication is encephalitis, or swelling of the brain. This occurs in roughly 1 out of every 1,000 measles cases and can cause seizures, deafness, or intellectual disability. In very rare cases, a fatal brain condition called SSPE (subacute sclerosing panencephalitis) can develop years after the initial infection, typically in people who had measles as young children. SSPE is always fatal and can appear 7 to 10 years after the original illness.
Young children under age five, adults over 20, pregnant women, and anyone with a weakened immune system face the highest risk of complications.
Treatment
There is no antiviral drug that kills the measles virus. Treatment focuses on managing symptoms: staying hydrated, controlling fever, and treating secondary infections like pneumonia with antibiotics if they develop.
Vitamin A supplementation is a standard part of measles treatment, especially in children. The World Health Organization recommends it because measles depletes the body’s vitamin A stores, and low levels are linked to worse outcomes. The benefit is greatest in children under two years old. In populations where vitamin A deficiency is common, supplementation has been shown to reduce the severity of the disease and lower the death rate.
Vaccination
The MMR (measles, mumps, rubella) vaccine is the primary tool for preventing measles. One dose is 93% effective against measles. Two doses raise that to 97%. In the United States, children typically receive the first dose at 12 to 15 months and the second at 4 to 6 years.
Because the virus has only one serotype, the vaccine provides durable protection. Most people who receive two doses are protected for life. The small percentage who don’t develop full immunity after vaccination are still partially protected through herd immunity, as long as enough people around them are vaccinated. When vaccination rates in a community drop below roughly 95%, measles outbreaks become possible because the virus is so efficient at finding unprotected people.